REFERENCES
Bajic, G., Maron, M. J., Adachi, Y., Onodera, T., McCarthy, K. R., McGee, C. E., . . . Schmidt, A. G. (2019). Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope. Cell host & microbe, 25 (6), 827-835 e826. doi:10.1016/j.chom.2019.04.003
Bart, S. A., Hohenboken, M., Della Cioppa, G., Narasimhan, V., Dormitzer, P. R., & Kanesa-Thasan, N. (2014). A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Science translational medicine, 6 (234), 234ra255. doi:10.1126/scitranslmed.3008761
Bernstein, D. I., Guptill, J., Naficy, A., Nachbagauer, R., Berlanda-Scorza, F., Feser, J., . . . Krammer, F. (2020). Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. The Lancet. Infectious diseases, 20 (1), 80-91. doi:10.1016/S1473-3099(19)30393-7
Chen, J., Skehel, J. J., & Wiley, D. C. (1999). N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proceedings of the National Academy of Sciences of the United States of America, 96 (16), 8967-8972. doi:10.1073/pnas.96.16.8967
Couch, R. B., Patel, S. M., Wade-Bowers, C. L., & Nino, D. (2012). A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PloS one, 7 (12), e49704. doi:10.1371/journal.pone.0049704
Dunand, C. J. H., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., . . . Wilson, P. C. (2016). Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell host & microbe, 19 (6), 800-813. doi:10.1016/j.chom.2016.05.014
Ekiert, D. C., Friesen, R. H., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., . . . Goudsmit, J. (2011). A highly conserved neutralizing epitope on group 2 influenza A viruses.Science, 333 (6044), 843-850. doi:10.1126/science.1204839
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., . . . Shu, Y. (2013). Human infection with a novel avian-origin influenza A (H7N9) virus. The New England journal of medicine, 368 (20), 1888-1897. doi:10.1056/NEJMoa1304459
Guo, L., Zhang, X., Ren, L., Yu, X., Chen, L., Zhou, H., . . . Wang, J. (2014). Human antibody responses to avian influenza A(H7N9) virus, 2013. Emerging infectious diseases, 20 (2), 192-200. doi:10.3201/eid2002.131094
Hu, Z., Liu, X., Jiao, X., & Liu, X. (2017). Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges.Vaccine, 35 (48), 6585-6590. doi:10.1016/j.vaccine.2017.10.010
Hu, Z., Shi, L., Xu, N., Wang, X., Hu, J., Zhao, J., . . . Cao, Y. (2020). Induction of cross-group broadly reactive antibody response by natural H7N9 avian influenza virus infection and immunization with inactivated H7N9 vaccine in chickens.Transboundary and emerging diseases . doi:10.1111/tbed.13705
Hu, Z., Zhao, J., Zhao, Y., Fan, X., Hu, J., Shi, L., . . . Liu, X. (2019). Hemagglutinin-Specific Non-neutralizing Antibody Is Essential for Protection Provided by Inactivated and Viral-Vectored H7N9 Avian Influenza Vaccines in Chickens. Frontiers in veterinary science, 6 , 482. doi:10.3389/fvets.2019.00482
Huang, K. A., Rijal, P., Jiang, H., Wang, B., Schimanski, L., Dong, T., . . . Townsend, A. R. (2019). Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans. Nature microbiology, 4 (2), 306-315. doi:10.1038/s41564-018-0303-7
Isakova-Sivak, I., & Rudenko, L. (2017). Tackling a novel lethal virus: a focus on H7N9 vaccine development. Expert review of vaccines, 16 (7), 1-13. doi:10.1080/14760584.2017.1333907
Jackson, L. A., Campbell, J. D., Frey, S. E., Edwards, K. M., Keitel, W. A., Kotloff, K. L., . . . Bellamy, A. R. (2015). Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. Jama, 314 (3), 237-246. doi:10.1001/jama.2015.7916
Jiang, W., Hou, G., Li, J., Peng, C., Wang, S., Liu, S., . . . Liu, H. (2019). Prevalence of H7N9 subtype avian influenza viruses in poultry in China, 2013-2018.Transboundary and emerging diseases, 66 (4), 1758-1761. doi:10.1111/tbed.13183
Kamal, R. P., Blanchfield, K., Belser, J. A., Music, N., Tzeng, W. P., Holiday, C., . . . York, I. A. (2017). Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies. J Virol . doi:10.1128/JVI.01202-17
Krammer, F., & Cox, R. J. (2013). The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines. Expert review of vaccines, 12 (12), 1369-1372. doi:10.1586/14760584.2013.850036
Li, Z., Wan, Z., Li, T., Xie, Q., Sun, H., Chen, H., . . . Ye, J. (2019). A novel linear epitope crossing Group 1 and Group 2 influenza A viruses located in the helix A of HA2 derived from H7N9. Veterinary microbiology, 228 , 39-44. doi:10.1016/j.vetmic.2018.11.002
Liu, D., Zhang, Z., He, L., Gao, Z., Li, J., Gu, M., . . . Liu, X. (2018). Characteristics of the emerging chicken-origin highly pathogenic H7N9 viruses: A new threat to public health and poultry industry. Journal of Infection, 76 (2), 217-220. doi:10.1016/j.jinf.2017.09.005
Liu, L., Nachbagauer, R., Zhu, L., Huang, Y., Xie, X., Jin, S., . . . Xu, J. (2017). Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.The Journal of infectious diseases, 215 (4), 518-528. doi:10.1093/infdis/jiw608
Liu, M., Song, T., Hua, S., Wu, A., & Jiang, T. (2015). Computational analysis of antigenic epitopes of avian influenza A (H7N9) viruses. Science China. Life sciences, 58 (7), 687-693. doi:10.1007/s11427-015-4886-4
Liu, Q., Mena, I., Ma, J., Bawa, B., Krammer, F., Lyoo, Y. S., . . . Richt, J. A. (2015). Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses. J Virol, 89 (14), 7401-7408. doi:10.1128/JVI.00031-15
Ma, M., Yang, Y., & Fang, L. (2018). Highly Pathogenic Avian H7N9 Influenza Viruses: Recent Challenges.Trends in microbiology . doi:10.1016/j.tim.2018.11.008
Ringe, R. P., Pugach, P., Cottrell, C. A., LaBranche, C. C., Seabright, G. E., Ketas, T. J., . . . Moore, J. P. (2019). Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes. Journal of virology, 93 (4). doi:10.1128/JVI.01656-18
Shi, J., Deng, G., Ma, S., Zeng, X., Yin, X., Li, M., . . . Chen, H. (2018). Rapid Evolution of H7N9 Highly Pathogenic Viruses that Emerged in China in 2017. Cell host & microbe, 24 (4), 558-568 e557. doi:10.1016/j.chom.2018.08.006
Shi, L., Hu, Z., Hu, J., Liu, D., He, L., Liu, J., . . . Liu, X. (2019). Single Immunization with Newcastle Disease Virus-Vectored H7N9 Vaccine Confers a Complete Protection Against Challenge with Highly Pathogenic Avian Influenza H7N9 Virus.Avian diseases, 63 (1), 61-67. doi:10.1637/11965-090118-Reg.1
Stadlbauer, D., Rajabhathor, A., Amanat, F., Kaplan, D., Masud, A., Treanor, J. J., . . . Krammer, F. (2017). Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.mSphere, 2 (6). doi:10.1128/mSphere.00502-17
Sun, Z., Shi, B., Meng, F., Ma, R., Hu, Q., Qin, T., . . . Liu, X. (2018). Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of H7N9 Influenza Viruses. Frontiers in microbiology, 9 , 2069. doi:10.3389/fmicb.2018.02069
Tan, G. S., Leon, P. E., Albrecht, R. A., Margine, I., Hirsh, A., Bahl, J., & Krammer, F. (2016). Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection. PLoS pathogens, 12 (4), e1005578. doi:10.1371/journal.ppat.1005578
Thornburg, N. J., Zhang, H., Bangaru, S., Sapparapu, G., Kose, N., Lampley, R. M., . . . Crowe, J. E., Jr. (2016). H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. The Journal of clinical investigation, 126 (4), 1482-1494. doi:10.1172/JCI85317
Wang, X., Jiang, H., Wu, P., Uyeki, T. M., Feng, L., Lai, S., . . . Yu, H. (2017). Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. The Lancet. Infectious diseases, 17 (8), 822-832. doi:10.1016/S1473-3099(17)30323-7
Wang, X., Sun, Q., Ye, Z., Hua, Y., Shao, N., Du, Y., . . . Wan, C. (2016). Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus. Experimental and therapeutic medicine, 12 (4), 2439-2446. doi:10.3892/etm.2016.3636
Wong, S. S., Jeevan, T., Kercher, L., Yoon, S. W., Petkova, A. M., Crumpton, J. C., . . . Webby, R. J. (2014). A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.Vaccine, 32 (35), 4571-4577. doi:10.1016/j.vaccine.2014.06.016
Yang, F., Xiao, Y., Lu, R., Chen, B., Liu, F., Wang, L., . . . Wu, H. (2020). Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus.Emerging microbes & infections, 9 (1), 664-675. doi:10.1080/22221751.2020.1742076
Yao, L., Chen, Y., Wang, X., Bi, Z., Xiao, Q., Lei, J., . . . Yan, L. (2020). Identification of antigenic epitopes in the haemagglutinin protein of H7 avian influenza virus.Avian pathology : journal of the W.V.P.A, 49 (1), 62-73. doi:10.1080/03079457.2019.1666971
Zhang, F., Bi, Y., Wang, J., Wong, G., Shi, W., Hu, F., . . . Gao, G. F. (2017). Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China.The Journal of infection, 75 (1), 71-75. doi:10.1016/j.jinf.2017.04.001